Apyx Medical Corp Cash And Cash Equivalents At Carrying Value

• Apyx Medical Corp showed a decrease of 0.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2008 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 20 years of available data (2008 to 2025), Apyx Medical Corp's Cash And Cash Equivalents At Carrying Value has grown by 1,137.9%.
• Historical annual values: Fiscal year 2025: $31.74 million | Fiscal year 2024: $31.74 million | Fiscal year 2023: $43.65 million | Fiscal year 2022: $10.19 million | Fiscal year 2021: $30.87 million | Fiscal year 2020: $41.92 million | Fiscal year 2019: $58.81 million | Fiscal year 2019: $32.42 million | Fiscal year 2018: $16.60 million | Fiscal year 2018: $40.66 million | Fiscal year 2017: $9.95 million | Fiscal year 2016: $14.46 million | Fiscal year 2015: $11.81 million | Fiscal year 2014: $5.73 million | Fiscal year 2013: $7.92 million | Fiscal year 2012: $4.16 million | Fiscal year 2011: $4.88 million | Fiscal year 2010: $3.83 million | Fiscal year 2009: $2.16 million | Fiscal year 2008: $2.56 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026